RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 162 filers reported holding RELAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,018,776 | -10.7% | 156,254 | +13.7% | 0.00% | 0.0% |
| Q1 2024 | $1,140,702 | +196.3% | 137,434 | +293.1% | 0.00% | +100.0% |
| Q4 2023 | $384,932 | +82.7% | 34,962 | +108.4% | 0.00% | 0.0% |
| Q2 2023 | $210,719 | -68.1% | 16,777 | -58.1% | 0.00% | -66.7% |
| Q1 2023 | $660,101 | +3.7% | 40,079 | -5.9% | 0.00% | 0.0% |
| Q4 2022 | $636,474 | -36.1% | 42,602 | -28.4% | 0.00% | -57.1% |
| Q2 2022 | $996,000 | – | 59,484 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |